RCUS
Arcus Biosciences Inc
26.40$
-1.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.1% | +18.1% | -8.3% | +5.6% | -8.1% | +0.5% | -7.0% | -9.4% | +16.9% | -12.5% | -7.3% | |
| – | -5.7% | +28.0% | -3.9% | +10.3% | -9.8% | +1.5% | -8.2% | -9.4% | +17.5% | -16.2% | -10.4% | |
| – | -31.0% | +45.7% | -15.7% | +28.8% | -25.4% | +28.0% | +29.2% | -4.0% | -6.7% | -9.5% | -25.4% | |
| – | -5.0% | +31.1% | -2.6% | +12.4% | -10.2% | +1.9% | -8.6% | -8.8% | +18.1% | -16.2% | -14.6% | |
| – | -25.0% | -4.8% | -17.5% | -36.4% | +19.0% | -16.0% | -4.8% | -30.0% | +14.3% | -56.3% | +414.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.7% | -7.4% | -6.0% | +24.7% | -3.2% | -6.0% | -15.8% | +2.3% | -5.6% | -6.9% | -2.7% | |
| – | -8.0% | +10.9% | -2.5% | +8.0% | +5.1% | -15.0% | +9.4% | +11.9% | -1.7% | -9.5% | -5.3% | |
| – | +22.2% | +0.0% | +0.0% | +0.0% | +9.1% | +0.0% | +0.0% | +8.3% | +0.0% | +0.0% | +0.0% | |
| – | +0.0% | -5.9% | -6.3% | -13.3% | +38.5% | +22.2% | +31.8% | +44.8% | +0.0% | -7.1% | -12.8% | |
| – | – | – | – | – | +2.1% | +0.0% | +102.1% | +1.0% | +1.0% | +1.0% | +1.0% | |
| – | -11.2% | +53.0% | -10.2% | -11.0% | -14.2% | +9.5% | +3.4% | -20.6% | +44.7% | -17.0% | -11.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.5% | +14.9% | +5.7% | +0.3% | +0.3% | +7.3% | +8.2% | +0.0% | +0.8% | +16.8% | +0.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.